BeOne Medicines Ltd.ONC

BeOne Medicines Ltd. Segments Disclosure

10-KFiled Feb 26, 20262 min read
Segment and Geographic Information
Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company operates in one segment: pharmaceutical products. Its chief operating decision maker is the Chief Executive Officer, who makes operating decisions, assesses performance, and allocates resources on a consolidated basis.
The primary measure of segment profitability for the Company’s operating segment is considered to be consolidated net income (loss). Significant segment expenses reviewed by the CODM on a regular basis included within net income (loss) include cost of product sales, research and development expenses and selling, general and administrative expenses which are separately presented on the Company’s consolidated statements of operations. Other segment items within net income (loss) include interest income, interest expense, other (expense) income, net and income tax expense.
The Company’s long-lived assets are primarily located in the U.S. and China.
Net product revenues by geographic area are based upon the location of the customer, and net other revenue is recorded in the jurisdiction in which the related income is expected to be sourced from. Total net revenues by geographic area are presented as follows:
 Year Ended December 31,
 202520242023
 $$$
U.S. - total revenue2,880,324 1,957,498 1,128,219 
Product revenue2,841,246 1,950,530 945,551 
Other revenue39,078 6,968 182,668 
China- total revenue1,679,531 1,411,307 1,101,951 
Product revenue1,659,363 1,390,699 1,093,091 
Other revenue20,168 20,608 8,860 
Europe- total revenue611,369 362,626 202,014 
Product revenue609,643 359,507 122,228 
Other revenue1,726 3,119 79,786 
Rest of world- total revenue171,809 78,810 26,595 
Product revenue171,809 78,810 28,982 
Other revenue— — (2,387)
Total Revenue5,343,033 3,810,241 2,458,779 

Historical Timeline

Fiscal YearFiled
2025Feb 26, 2026Showing above
2024Feb 27, 2025
2023Feb 26, 2024
2022Feb 27, 2023
2021Feb 28, 2022
2020Feb 25, 2021
2019Mar 2, 2020
2018Feb 28, 2019
2017Feb 28, 2018

About Segments Disclosures

Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.

Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.

Other Available Disclosures

Income TaxesRevenueEarnings Per SharePP&EGoodwill & IntangiblesLeasesDebtCommitmentsStock CompensationNew StandardsPay vs Performance